Please provide your email address to receive an email when new articles are posted on . IRVINE, Calif. — Alphagan P (brimonidine tartrate ophthalmic solution, Allergan) 0.15% will be on pharmacy ...

Brimonidine Tartrate Ophthalmic Solution, 0.1%, is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The Food and Drug ...

Alembic intros generic Alphagan P ophthalmic solution Brimonidine Tartrate 0.15% is an alpha-adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure in patients with ...

Aug. 25, 2005 — The U.S. Food and Drug Administration (FDA) has approved once-daily perindopril erbumine tablets for use alone or in combination with concurrent therapy to reduce the risk of ...

IRVINE, Calif. — A federal court of appeals has upheld a lower court ruling dismissing Allergan’s lawsuit against Alcon and Bausch & Lomb for patent infringement on its glaucoma drug Alphagan. The ...

Allergan Inc., a maker of eye and beauty products, accused Canadian generic drug maker Apotex Inc. of infringing five U.S. patents for preparations used in the treatment of glaucoma. Allergan said in ...

SAN FRANCISCO (MarketWatch) -- Allergan Inc. after Friday's closing bell said that a new formulation of its Alphagan treatment, used to lower intraocular pressure in patients with open-angle glaucoma ...